MEET OUR SPEAKERS

Syed Zaferuddin is a Pharmacovigilance & Medical Device vigilance professional working as Global Vigilance Manager & QPPV at Julphar UAE. In past worked for companies like Jamjoom Pharma, TCS, Cognizant and Clinnovo. He is a speaker for World Drug Safety Congress in Europe and America. Skilled in Good Clinical Practice (GCP), Pharmacovigilance, Medical Device vigilance, Drafting Agreements, management of ICSR, aggregate reports, Pharmacovigilance intelligence, PV QMS, PV safety database and PV LMS. A strong legal professional with a Master’s Degree focused on Pharmacology. Also heading an NGO aims to increase the ICSR reporting culture in the Middle East.

Dr. Emad Eldin Munsour is a supervisor pharmacist at the Pharmacy and Drug Control Department, Ministry of Public Health (MoPH), Qatar. He has completed his PhD in pharmacy practice from Universiti Sains Malaysia, Penang, Malaysia. His professional experience started as a drug information and clinical pharmacist at Sri Ramakrishna hospital; Lecturer of Pharmacy Practice Department at University of Medical Sciences and Technology and Regulatory Affairs Manager (East Africa) at Hikma Pharmaceuticals Ltd.

He led the development of Qatar National Formulary (QNF) as a website and mobile application, Dr. Emad also served in the capacity of QNF editor and committee member from January 2013 till now. He participated in the comprehensive restructuring of Qatar’s drug regulatory teams and cross-functional processes. Dr. Emad is the focal point, Qatar Pharmacovigilance Center (Associate Member of Uppsala Monitoring Center, WHO). He served as the coordinator for Qatar National Drug Coding Project, Qatar Pharmaceutical Track and Trace System and Qatar National Medicines Security Strategy.

Dr. Emad served as an external member, the Graduate Supervisory Committee, College of Pharmacy, Qatar University and as a representative of the Pharmacy and Drug Control Department for Qatar’s National Health strategy (2018-2022).

Mick Foy has been with the MHRA for more than 35 years, he is a member of the MHRA’s Senior Leadership team.

He has been manager of the Vigilance Intelligence and Research Group for 10 years and in 2019 become Head of Pharmacovigilance Strategy.

Amongst his responsibilities is to lead MHRA efforts to build PV capabilities in other countries particularly low and middle income countries as part of a global initiative with the Bill and Melinda Gates Foundation and WHO.

Mick continues to have oversight of the operation of the UK’s Yellow Card Scheme and the MHRA’s signal detection systems.

He is currently leading the MHRA’s transformation of vigilance systems with a remit to develop common IT and methodologies for medicines and devices.

Mick is Chair of the MedDRA Management Committee, and a member of the Uppsala Monitoring Centre Board.